» Eğitim Durumu

» Akademik Unvanlar

» İş Tecrübesi

» Yayınlar

SCI-SSCI, SCI Expanded ve AHCI Kapsamındaki Yayınları

  • BÖLEK HATICE,SERTESEN ÇAMÖZ ELIF,KUZU ÖMER FARUK,TURAL DENIZ,SIM YILDIRIM SAADET,SENDUR MEHMET ALI NAHIT,UÇAR GÖKHAN,ISIK SELVER,HACIOGLU MUHAMMET BEKIR,ÇIÇIN IRFAN,ARSLAN ÇAGATAY,SEZGIN GÖKSU SEMA,SEVER ÖZLEM NURAY,KARAÇIN CENGIZ,KARADURMUS NURI,ÖZGÜROGLU MUSTAFA,YEKEDÜZ EMRE,ÜRÜN YÜKSEL, Treatment Patterns and Attrition in Metastatic Renal Cell Carcinoma: Real-Life Experience from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database, Clinical Genitourinary Cancer, vol. 23, no. 1, 2025
  • Gökmen Ivo,DEMIR NAZAN,PEKER PINAR,ÖZCAN ERKAN,AKGÜL FAHRI,BAYRAKÇI ISMAIL,DIVRIKLIOGLU DIDEM,ERDOGAN BÜLENT,TOPALOGLU SERNAZ,HACIOGLU MUHAMMET BEKIR, Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance, Frontiers in Oncology, 2024 (Aralık 2024)
  • ILHAN YUSUF,BIR YÜCEL KADRIYE,HACIOGLU MUHAMMET BEKIR, Concerns and Insights on Timing of Immunotherapy and Radiotherapy in Head and Neck Cancer: A Response to Janopaul-Naylor Et Al, head and neck, 2024 (Kasım 2024)
  • URUT DEVRIM ULAS,KARABULUT DERYA,HEREKLIOGLU SAVAS,ÖZDEMIR GÜLSAH,ÇIÇIN BERKIN ANIL,HACIOGLU MUHAMMET BEKIR,SÜT NECDET,TUNÇBILEK NERMIN, Diffusion tensor imaging: survival analysis prediction in breast cancer patients, Die Radiologie, vol. 64, pp. 54-59, 2024 (Kasım 2024)
  • KÖSTEK OSMAN,DEMIREL AHMET,HACIOGLU MUHAMMET BEKIR,TASTEKIN DIDEM,KARABULUT SENEM,gündogdu abidin,SEVER NADIYE,AYHAN MURAT,Çelebi Abdussamet,MAJIDOVA NARGIZ,YASAR ALPER,AGYOL YESIM,EREL PINAR,KOCAASLAN ERKAM,Güren Ali Kaan,ARIKAN ÜNVEREN RUKIYE,ISIK SELVER,ERCELEP ÖZLEM,SEZGIN GÖKSU SEMA,ALANDAG CELAL,BILGETEKIN IREM,CANER BURCU,Sahin Ahmet Bilge,GÜLMEZ AHMET,AKAGÜNDÜZ BARAN,KÖSE FATIH,KAPLAN MUHAMMET ALI,DOGAN ENDER,SAKALAR TEOMAN,GÜVEN DENIZ CAN,GÜRBÜZ MUSTAFA,ERGÜN YAKUP,KARAAGAÇ MUSTAFA,TÜRKER SEMA,ÖZKUL ÖZLEM,YILDIZ BIROL,SAHIN SÜLEYMAN,DEMIRAY ATIKE GÖKÇEN,SARI MURAT,ERDOGAN BÜLENT,ÇAKMAK ÖKSÜZOGLU ÖMÜR BERNA,KILIÇKAP SAADETTIN,BILICI AHMET,BAYOGLU IBRAHIM VEDAT,TOPALOGLU SERNAZ,ÇIÇIN IRFAN, The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing, Journal of Chemotherapy, vol. 36, no. 7, pp. 613-621, 2024 (Kasım 2024)
  • BAYOGLU IBRAHIM VEDAT, Hüseynov Javid, TOPAL ALPER, SEVER NADIYE, Majidova Nargiz, Çelebi Abdussamet, YASAR ALPER, ARIKAN RUKIYE, ISIK SELVER, HACIOGLU MUHAMMET BEKIR, ERCELEP ÖZLEM, SARI MURAT, ERDOGAN BÜLENT, HACIBEKIROGLU ILHAN, TOPALOGLU SERNAZ, KÖSTEK OSMAN, ÇIÇIN IRFAN, PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score, Journal of Clinical Medicine, vol. 12, 2023
    1
    ATIF
  • Gökmen Ivo,TASTEKIN EBRU,DEMIR NAZAN,ÖZCAN ERKAN,AKGÜL FAHRI,HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,TOPALOGLU SERNAZ,ÇIÇIN IRFAN, Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer, Current Issues in Molecular Biology, vol. 45, no. 10, pp. 7803-7812, 2023
    1
    ATIF
  • ERDOGAN BÜLENT, ÖZCAN ERKAN, Gökmen Ivo, GÖKYER ALI, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, TOPALOGLU SERNAZ, ÇIÇIN IRFAN, Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib, Medknow, vol. 19, no. 3, 2023
    3
    ATIF
  • HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, BARDAKÇI MURAT, ALGIN EFNAN, GÜLBAGCI BURCU, HACIBEKIROGLU ILHAN, Hamdard Jamshid, ÖLMEZ ÖMER FATIH, AKKUS MEHMET HADI, ÇAKMAK ÖKSÜZOGLU ÖMÜR BERNA, SEZGIN GÖKSU SEMA, DAE SHUTE AILIA, SÜMBÜL AHMET TANER, UGRAKLI MUZAFFER, KARAAGAÇ MUSTAFA, SAHIN ELIF, ÇABUK DEVRIM, ÖZER ÖZDEN, YAVUZSEN TUGBA, ARIKAN RUKIYE, KÖSTEK OSMAN, ATCI MUHAMMED MUSTAFA, SAKIN ABDULLAH, DELIGÖNÜL ADEM, BAYIR GARBIOGLU DUYGU, DINCER MURAT, ÜNSAL OKTAY, YAZICI OZAN, ZEYNELGIL ESRA, GÜLMEZ AHMET, HARPUTLUOGLU HAKAN, EROL CIHAN, SENDUR MEHMET ALI NAHIT, AYTEKIN AYDIN, AKAGÜNDÜZ BARAN, ÖNER IREM, ER ÖZLEM, ÖZTOSUN BUGRA, GÜMÜS MAHMUT, SELÇUKBIRICIK FATIH, AYKAN MUSA BARIS, KARADURMUS NURI, DEGERLI EZGI, DEMIRCI NEBI SERKAN, TÜRKMEN BEKMEZ ESMA, SAKALAR TEOMAN, Seçmeler Saban, TANRIVERDI ÖZGÜR, ALKAN ALI, KEMAL YASEMIN, ÜNAL ÇAGLAR, IRIAGAÇ YAKUP, ALAN ÖZKAN, BALLI SEVINÇ, ÜRÜN YÜKSEL, ÖZCAN ERKAN, TURHAL NAZIM SERDAR, ÇIÇIN IRFAN, Major and minor salivary gland cancers: A multicenter retrospective study, Wiley, vol. 45, 2023
  • KÜÇÜKARDA AHMET, ERDOGAN BÜLENT, GÖKYER ALI, sayin Sezin, Gökmen Ivo, ÖZCAN ERKAN, HACIOGLU MUHAMMET BEKIR, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma, SUPPORTIVE CARE IN CANCER, vol. 30, no. 3, pp. 2131-2139, 2022
    1
    ATIF
  • TOPAL ALPER, sayin Sezin, GÖKYER ALI, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, UZUNOGLU SERNAZ, ERDOGAN BÜLENT, ÇIÇIN IRFAN, Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience, Journal of BUON, vol. 26, no. 4, pp. 1628-1634, 2021
  • GÖKYER ALI, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, sayin Sezin, CANDEMIR NURAY, HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment, Journal of BUON, vol. 26, no. 3, pp. 1034-1039, 2021
  • ERDOGAN BÜLENT, KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, GÖKYER ALI, KÜÇÜKARDA AHMET, ÖZCAN ERKAN, Gökmen Ivo, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?, Journal of BUON, vol. 26, no. 5, pp. 2196-2201, 2021
  • GÖKYER ALI, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, Gökmen Ivo, ÖZCAN ERKAN, sayin Sezin, TASTEKIN EBRU, HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma, Tumori Journal, 2021
  • KOCA SINAN,BESIROGLU MEHMET,ÖZÇELIK MELIKE,Karaca Mustafa,Bilici Mehmet,HACIOGLU MUHAMMET BEKIR,Dogu Gamze G,Kaplan Nihal B,Oruç Zeynep,AYDIN DINÇER,Dane Faysal, Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study, Journal of Oncology Pharmacy Practice, pp. 107815522092407, 2020
  • KOCA SINAN, BESIROGLU MEHMET, ÖZÇELIK MELIKE, KARACA MUSTAFA, BILICI MEHMET, HACIOGLU MUHAMMET BEKIR, GÖKÖZ DOGU GAMZE, BOZDAG KAPLAN NIHAL, ORUÇ ZEYNEP, AYDIN DINÇER, DANE FAYSAL, Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study, Journal of Oncology Pharmacy Practice, vol. 27, no. 3, pp. 541-546, 2020
  • GÖKYER ALI, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, UZUNOGLU SERNAZ, KULA OSMAN, KURT NAZMI, ÜSTÜNDAG SEDAT, ERDOGAN BÜLENT, ÇIÇIN IRFAN, Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study, International Journal of Clinical Oncology, vol. 25, no. 10, pp. 1757-1762, 2020
    2
    ATIF
  • SEDEF ALI MURAT,KÖSE FATIH,SÜMBÜL AHMET TANER,BESEN ALI AYBERK,HACIOGLU MUHAMMET BEKIR,GÜNALDI MERAL,NAYIR ERDINÇ,TANRIVERDI ÖZGÜR,ARPACI ERKAN,ABALI HÜSEYIN,ÖZYILKAN ÖZGÜR, Addition of taxanes to combination chemotherapy in distalintestinal gastric cancer is more beneficial than proximalones: A multicenter retrospective study of Turkish OncologyGroup, Journal of BUON, vol. 24, no. 2, pp. 1-6, 2019
  • TURAL DENIZ,KARACA MUSTAFA,ZIRTILOGLU ALISAN,HACIOGLU MUHAMMET BEKIR,SENDUR MEHMET ALI NAHIT,ÖZET AHMET, Receptor discordances in locally advanced breast cancer afterneoadjuvant chemotherapy and their effects on survival, Journal of BUON, vol. 24, no. 1, pp. 20-25, 2019
    4
    ATIF
  • HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN,KURT NAZMI,KÜÇÜKARDA AHMET,GÖKYER ALI,USTABASIOGLU FETHI EMRE,KARATAS FATIH,TUNÇBILEK NERMIN,UZUNOGLU SERNAZ,BILICI AHMET,ÇIÇIN IRFAN,ERDOGAN BÜLENT, Comparison of skeletal muscle mass loss in patients withmetastatic colorectal cancer treated with regorafenib orTAS-102, Journal of BUON, vol. 24, no. 5, pp. 2198-2204, 2019
    1
    ATIF
  • GÖKYER ALI,KÜÇÜKARDA AHMET,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,SUNAL BARAN SERDAR,DEMIRCAN NAZIM CAN,UZUNOGLU SERNAZ,SOLAK SERDAR,ISSEVER KUBILAY,ÇIÇIN IRFAN,ERDOGAN BÜLENT, Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib, Clinical and Translational Oncology, vol. 21, no. 11, pp. 1518-1523, 2019
  • DEGIRMENCIOGLU SERKAN,TANRIVERDI ÖZGÜR,MENEKSE SERKAN,DOGAN MUTLU,HACIOGLU MUHAMMET BEKIR,OKTAY ESIN,DILEK ERDEM,ARPACI ERKAN,OYAN ULUÇ BASAK,TURHAL SERDAR,YILMAZ MERVE,PILANCI KEZBAN,SAKIN ABDULLAH,ARAZ MURAT,ÇOKMERT SUNA,ÖZDEMIR ÖZLEM,SEN ERDEM,NAYIR ERDINÇ, A retrospective analysis on first-line bevacizumab, cetuximab,and panitumumab-containing regimens in patients with RASwildmetastatic colorectal cancer: A Collaborative Study byTurkish Oncology Group (TOG), Journal of BUON, vol. 24, no. 1, pp. 242-248, 2019
  • O. KÖSTEK, Y. BOZKAYA, B. M. HACIOGLU, N. Ö. YILDIRIM, E. YILMAZ, C. N. DEMIRCAN, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, N. ZENGIN, Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?, Archives of Iranian Medicine, vol. 22, no. 1, pp. 236-241, 5, 2019
  • O. KÖSTEK, B. M. HACIOGLU, A. SAKIN, T. DEMIR, M. SARI, Ö. ÖZKUL, M. ARAZ, F. A. DOGAN, C. N. DEMIRCAN, S. UZUNOGLU, I. ÇIÇIN, B. ERDOGAN, Regorafenib or rechallenge chemotherapy: Which is more effective in the third-line treatment of metastatic colorectal cancer?, CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 83, no. 1, pp. 115-122, 1, 2019
  • S. DEGIRMENCIOGLU, Ö. TANRIVERDI, S. MENEKSE, M. DOGAN, B. M. HACIOGLU, E. OKTAY, E. DILEK, E. ARPACI, B. U. OYAN, S. TURHAL, M. YILMAZ, K. PILANCI, A. SAKIN, M. ARAZ, S. ÇOKMERT, Ö. ÖZDEMIR, E. SEN, E. NAYIR, A retrospective analysis on first-line bevacizumab, cetuximab,and panitumumab-containing regimens in patients with RASwildmetastatic colorectal cancer: A Collaborative Study byTurkish Oncology Group (TOG), Journal of BUON, vol. 24, no. 1, pp. 242-248, 1, 2019
  • D. TURAL, M. KARACA, A. ZIRTILOGLU, B. M. HACIOGLU, N. A. M. SENDUR, A. ÖZET, Receptor discordances in locally advanced breast cancer afterneoadjuvant chemotherapy and their effects on survival, Journal of BUON, vol. 24, no. 1, pp. 20-25, 1, 2019
  • A. GÖKYER, A. KÜÇÜKARDA, O. KÖSTEK, B. M. HACIOGLU, S. B. SUNAL, C. N. DEMIRCAN, S. UZUNOGLU, S. SOLAK, K. ISSEVER, I. ÇIÇIN, B. ERDOGAN, Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib, Clinical and Translational Oncology, 3, 2019
    1
    ATIF
  • O. KÖSTEK, E. YiLMAZ, B. M. HACIOGLU, C. N. DEMIRCAN, A. GÖKYER, S. UZUNOGLU, N. TUNÇBILEK, I. ÇIÇIN, B. ERDOGAN, Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer, Cancer Chemotherapy and Pharmacology, vol. 83, no. 4, pp. 735-742, 4, 2019
    2
    ATIF
  • Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer? Köstek O, Hacıoğlu MB, Sakin A, Demir T, Sarı M, Ozkul O, Araz M, Doğan AF, Demircan NC, Uzunoğlu S, Çiçin İ, Erdoğan B. Cancer Chemother Pharmacol. 2018 Oct 29. doi: 10.1007/s00280-018-3713-6 (Kasım 2018)
    4
    ATIF
  • Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma. Karatas F, Sahin S, Aytekin A, Hacioglu MB, Imamoglu GI, Altinbas M. J Cancer Res Ther. 2018 Jul-Sep;14(5):1149-1151. doi: 10.4103/0973-1482.188293. (Eylül 2018)
  • Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma. Kostek O, Yilmaz E, Bekir Hacıoglu M, Erdogan B, Kodaz H, Turkmen Bekmez E, Hacibekiroglu I, Uzunoglu S, Tuncbilek N, Cicin I. J BUON. 2018 Jul-Aug;23(4):979-984. (Eylül 2018)
    1
    ATIF
  • Renal cellcarcinoma presenting with heart metastasis without inferior vena caval and right atrialinvolvement. Sahin S, Karatas F, Hacioglu MB, Aytekin A, Cilbir E, Conkbayir I. J Cancer Res Ther. 2018 Jan-Mar;14(2):457-458. (Mart 2018)
  • KARATAS FATIH,SAHIN SÜLEYMAN,AYTEKIN AYDIN,HACIOGLU MUHAMMET BEKIR,IMAMOGLU GÖKSEN INANÇ,ALTINBAS MUSTAFA, Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma, Journal of Cancer Research and Therapeutics, vol. 14, no. 5, pp. 1149-1151, 2018
  • SAHIN SÜLEYMAN,KARATAS FATIH,HACIOGLU MUHAMMET BEKIR,AYTEKIN AYDIN,ÇILBIR EBRU,CONKBAYIR ISIK, Renal cell carcinoma presenting with heart metastasis without inferior vena caval and right atrial involvement, Journal of Cancer Research and Therapeutics, vol. 14, no. 2, pp. 457-458, 2018
  • KÖSTEK OSMAN,YILMAZ ERDEM,HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,KODAZ HILMI,BEKMEZ ESMA TURKMEN,HACIBEKIROGLU ILHAN,UZUNOGLU SERNAZ,TUNCBILEK NERMIN,ÇIÇIN IRFAN, Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma, Journal of BUON, vol. 23, no. 4, pp. 979-984, 2018
  • Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis. Muhammet Hacioglu B, Kostek O, Erdogan B, Uzunoglu S, Cicin I. J BUON. 2017 May-Jun;22(3):586-591. (Mayıs 2017)
  • Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer. Sahin S, Karatas F, Erdem GU, Hacioglu B, Altundag K. . Am Surg. 2017 Apr 1;83(4):359-364. (Nisan 2017)
  • K-RAS and N-RAS mutations in testicular germ cell tumors.Hacioglu BM, Kodaz H, Erdogan B, Cinkaya A, Tastekin E, Hacibekiroglu I, Turkmen E, Kostek O, Genc E, Uzunoglu S, Cicin I.Bosn J Basic Med Sci. 2017 Apr 20. doi: 10.17305/bjbms.2017. (Nisan 2017)
    6
    ATIF
  • Comparison of survival with somatostatin analog and chemotherapy and Prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less. Özaslan E, Karaca H, Koca S, Sevinç A, Hacioğlu B, Özkan M, Özçelik M, Duran AO, Hacibekiroğlu İ, Yildiz Y, Tanriverdi Ö, Menekşe S, Aksoy A, Bozkurt O, Urvay S, Uysal M,Demir H, Çiltaş A, Dane F. Anticancer Drugs. 2017 Feb;28(2):222-229. (Şubat 2017)
    1
    ATIF
  • ÖZASLAN ERSIN,KARACA HALIT,KOCA SINAN,SEVINÇ ALPER,HACIOGLU MUHAMMET BEKIR,ÖZKAN METIN,ÖZÇELIK MELIKE,OCAK DURAN AYSE,HACIBEKIROGLU ILHAN,YILDIZ YASAR,TANRIVERDI ÖZGÜR,MENEKSE SERKAN,AKSOY ASUDE,BOZKURT OKTAY,URVAY SEMIHA,UYSAL MÜKREMIN,DEMIR HACER,ÇILTAS AYDIN,DANE FAYSAL, Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20 or less, Anti-Cancer Drugs, vol. 28, no. 2, pp. 222-229, 2017
  • HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN,ERDOGAN BÜLENT,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis, Journal of BUON, vol. 22, no. 3, pp. 586-591, 2017
  • HACIOGLU MUHAMMET BEKIR,KODAZ HILMI,ERDOGAN BÜLENT,ÇINKAYA AHMET,TASTEKIN EBRU,HACIBEKIROGLU ILHAN,TÜRKMEN ESMA,KÖSTEK OSMAN,GENÇ EZGI,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, K-RAS and N-RAS mutations in testicular germ cell tumors, Bosnian Journal of Basic Medical Sciences, vol. 17, no. 2, pp. 159-163, 2017
  • SAHIN SÜLEYMAN,KARATAS FATIH,ERDEM GÖKMEN UMUT,HACIOGLU MUHAMMET BEKIR,ALTUNDAG KADRI, Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer, AMERICAN SURGEON, vol. 83, no. 4, pp. 359-364, 2017
  • Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas. İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi10, Yusuf Günaydin11, Serkan Menekşe12, Berna Öksüzoğlu, Asude Aksoy13, Bülent Erdogan, M Bekir Hacıoglu, Erkan Arpaci14, Alper Sevinç1.Balkan Med J 2016;33:517-24 (Eylül 2016)
    2
    ATIF
  • Impact of active smokingon survival of patients with metastatic lung adenocarcinoma harboring an epidermal growthfactor receptor (EGFR) mutation. Erdogan B, Kodaz H, Karabulut S, Cinkaya A, Tozkir H, Tanriverdi O, Cabuk D,Hacioglu MB, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. Bosn J Basic MedSci. 2016 Jul 1.doi:10.17305/bjbms.2016.1380. (Temmuz 2016)
    1
    ATIF
  • Effectiveness and safety ofcabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkishpatients (The Anatolian Society of Medical Oncology).Süner A, Aydın D, Hacıoğlu MB, Doğu GG, İmamoğlu GI, Menekşe S, Pilancı KN,Yazıcı ÖK, Koca D, Karaağaç M, Akyol M, Akman T, Ergen S, Avcı N, Kaçan T, Bozkurt O,Kefeli U, Urakçı Z, Araz M, Arpacı E, Harputlu H, Sevinç A. Eur Rev Med Pharmacol Sci. 2016Apr;20(7):1238-43. (Nisan 2016)
  • ÇIÇIN IRFAN,ÖZATLI TAHSIN,TÜRKMEN ESMA,ÖZTÜRK TÜRKAN,ÖZÇELIK MELIKE,ÇABUK DEVRIM,GÖKDURNALI AYSE,BALVAN ÖZLEM,YILDIZ YASAR,SEKER METIN,ÖZDEMIR NURIYE,YAPAR BURCU,TANRIVERDI ÖZGÜR,GÜNAYDIN YUSUF,MENEKSE SERKAN,ÇAKMAK ÖKSÜZOGLU ÖMÜR BERNA,AKSOY ASUDE,ERDOGAN BÜLENT,HACIOGLU MUHAMMET BEKIR,ARPACI ERKAN,SEVINÇ ALPER, Predictive and Prognostic Factors in Ovarian and UterineCarcinosarcomas, Balkan Medical Journal, vol. 33, no. 5, pp. 517-524, 2016
  • SÜNER ALI,AYDIN DINÇER,HACIOGLU MUHAMMET BEKIR,GÖKÖZ DOGU GAMZE,IMAMOGLU GÖKSEN INANÇ,MENEKSE SERKAN,PILANCI KEZBAN NUR,YZICI ÖMER,KOCA DOGAN,KARAAGAÇ MUSTAFA,AKYOL MURAT,AKMAN TÜLAY,SELÇUK ERGEN,AVCI NILÜFER,KAÇAN TURGUT,BOZKURT OKTAY,KEFELI UMUT,URAKÇI ZUHAT,ARAZ MURAT,ARPACI ERKAN,HARPUTLUOGLU HAKAN,SEVINÇ ALPER, Effectiveness and safety of cabazitaxel chemotherapy for metastatic castrationresistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology), European Review for Medical and Pharmacological Sciences, vol. 20, no. 7, pp. 1238-1243, 2016
  • ERDOGAN BÜLENT,KODAZ HILMI,KARABULUT SENEM,ÇINKAYA AHMET,TOZKIR HILMI,TANRIVERDI ÖZGÜR,ÇABUK DEVRIM,HACIOGLU MUHAMMET BEKIR,TÜRKMEN ESMA,HACIBEKIROGLU ILHAN,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation, Bosnian Journal of Basic Medical Sciences, vol. 16, no. 4, pp. 280-285, 2016
  • How long should we maintain anti-HER2 therapyf or metastatic breast cancer patients with complete remission? Hacioglu B, Akin S, Babacan T, Sever AR, Altundag K. Future Oncol. 2015;11(20):2799-801. (Kasım 2015)
  • A rare coexistence—Chronic lymphocytic leukemia and Kaposi sarcoma: Case report and review of the literature. Hacioglu MB, Sahin S, Karatas F, Aytekin A. J Cancer Res Ther. 2015 Oct-Dec;11(4):954-6. (Ekim 2015)
  • Krukenberg tumor presenting with amenorrhea as the sole initial symptom: Casereportandreview of theliterature. Sahin S, Karatas F, Hacioglu B, Aytekin A, Imamoglu I, Koseoglu N, Sari E, AltinbasM. J Cancer Res Ther. 2015 Oct-Dec;11(4):1024. (Ekim 2015)
  • Does eribulinMesylate cause recurrent transient diplopia? Karatas F, Hacioglu B, Akin S, Babacan T, Sever AR, Altundag K. J BUON. 2015 Sep-Oct;20(5):1379. (Eylül 2015)
  • Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients. Hacioglu B, Akin S, Sever AR, Altundag K. Future Oncol. 2015 Sep;11(18):2495-7. (Eylül 2015)
  • Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure- Second highest level of CA 19-9 in the literature. Aytekin A, Sahin S, Bekir Hacioglu M, Karatas F, Ince M. J BUON. 2015 Jul-Aug;20(4):1169-70. (Temmuz 2015)
  • AYTEKIN AYDIN,SAHIN SÜLEYMAN,HACIOGLU MUHAMMET BEKIR,KARATAS FATIH,INCE MERVE, Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure-Second highest level of CA 19-9 in the literature., Journal of BUON, vol. 20, no. 4, pp. 1169-1170, 2015
  • KARATAS FATIH,HACIOGLU MUHAMMET BEKIR,AKIN SERKAN,BABACAN TANER,SEVER ALI RIZA,ALTUNDAG KADRI, Does eribulin mesylate cause recurrent transient diplopia?, Journal of BUON, vol. 20, no. 5, pp. 1379, 2015
  • SAHIN SÜLEYMAN,KARATAS FATIH,HACIOGLU MUHAMMET BEKIR,AYTEKIN AYDIN,IMAMOGLU GÖKSEN INANÇ,KÖSEOGLU NAZIYET,SARI EBRU,ALTINBAS MUSTAFA, Krukenberg tumor presenting with amenorrhea as the sole initial symptom: Case report and review of the literature, Journal of Cancer Research and Therapeutics, vol. 11, no. 4, pp. 1024, 2015
  • HACIOGLU MUHAMMET BEKIR,AKIN SERKAN,BABACAN TANER,SEVER ALI RIZA,ALTUNDAG KADRI, How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?, Future Oncology, vol. 11, no. 20, pp. 2799-2801, 2015
  • HACIOGLU MUHAMMET BEKIR,SAHIN SÜLEYMAN,KARATAS FATIH,AYTEKIN AYDIN, A rare coexistence - Chronic lymphocytic leukemia and Kaposi sarcoma: Case report and review of the literature, Journal of Cancer Research and Therapeutics, vol. 11, no. 4, pp. 954-956, 2015
  • HACIOGLU MUHAMMET BEKIR,AKIN SERKAN,SEVER ALI RIZA,ALTUNDAG KADRI, Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients., Future Oncology, vol. 11, no. 18, pp. 2495-2497, 2015

Uluslararası Hakemli Dergilerde Yayınlanan Makaleler

  • ANDAÇ BURAK,TOPALOGLU SERNAZ,ERDOGAN BÜLENT,HACIOGLU MUHAMMET BEKIR,YEKDES ALI CEM,YILDIZ ÇAGLA,ÇIÇIN IRFAN, Overview of Clinical, Pathological and Treatment Features of the Patients with Endometrium Cancer: A Single Center Study, Eurasian Journal of Medical Advances, vol. 4, no. 2, pp. 102-109, 2024
  • AKGÜL FAHRI,CAN NURAY,TOPUZ CANBERK,Gökmen Ivo,ÖZCAN ERKAN,HACIOGLU MUHAMMET BEKIR,TOPALOGLU SERNAZ,ERDOGAN BÜLENT,ÇIÇIN IRFAN, Pilomatrix Carcinoma with Pulmonary Metastasis, Journal of Oncological Sciences, vol. 10, no. 1, pp. 69-72, 2024
  • KÜÇÜKARDA AHMET, GÖKYER ALI, YÜRÜT ÇALOGLU VUSLAT, ÇALOGLU HASAN MURAT, Gökmen Ivo, ÖZCAN ERKAN, HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, TOPALOGLU SERNAZ, Prognostic Effect of Immunohistochemical Scoring on Survival in Glioblastoma, Eurasian Journal of Medicine and Investigation, 2023
  • KÜÇÜKARDA AHMET, GÖKYER ALI, Gökmen Ivo, ÖZCAN ERKAN, HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, TOPALOGLU SERNAZ, ÇIÇIN IRFAN, Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide, Elsevier BV, vol. 46, no. 5, pp. 301-309, 2022
    2
    ATIF
  • KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR, Effect of Somatostatin Analogs on Prostate Volume, Medeniyet Medical Journal, vol. 34, no. 1, pp. 76-81, 2019
  • Demircan Nazim Can, Köstek Osman, Gökyer Ali, Küçükarda Ahmet, Hacioglu Muhammet Bekir, Erdogan Bülent, Uzunoglu Sernaz, Çiçin Irfan, The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases, Journal of Surgery and Medicine, vol. 3, no. 12, pp. 841-844, 2019
  • O. KÖSTEK, B. M. HACIOGLU, Effect of Somatostatin Analogs on Prostate Volume, Medeniyet Medical Journal, vol. 34, no. 1, pp. 76-81, 6, 2019
  • Enzalutamide and Cancer. B Erdogan, O Kostek, M Bekir Hacioglu EJMO 2018;2(3):121–129 (Mart 2018)
  • ERDOGAN BÜLENT,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR, Enzalutamide in Prostate Cancer, A Review on Enzalutamide and cancer, Eurasian Journal of Medicine and Oncology, vol. 2, no. 3, pp. 121-129, 2018
  • Assessment of Prognostic Factors in Epithelial Ovarian Cancer. Yilmaz Onal, Osman Kostek, Muhammet Bekir Hacioglu, Bulent Erdogan, HilmiKodaz, Esma Turkmen Bekmez, Ilhan Hacibekiroglu, Sernaz Uzunoglu, Irfan Cicin. EJMO 2017;1(2):61–68 (Ekim 2017)
  • Clinical features of the patient with multiple primary tumors: Single center experience. Gokyer A, Kostek O, Hacioglu MB, Erdogan B, Kodaz H, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. North Clin Istanb. 2017 May 10;4(1):43-51. (Mayıs 2017)
  • KODAZ HILMI,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,KODAZ ELPEN ÇAGNUR,HACIBEKIROGLU ILHAN,TÜRKMEN ESMA,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer, Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 1-7, 2017
  • GÖKYER ALI,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,KODAZ HILMI,TÜRKMEN ESMA,HACIBEKIROGLU ILHAN,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience, Northern Clinics of Istanbul, vol. 4, no. 1, pp. 43-51, 2017
  • KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,ORMAN SEVAL,ÇETIN CEREN,KODAL NIL SU,ERDOGAN BÜLENT,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, A Rare Cause of Acute Kidney Injury: Renal ArterialThrombosis in a Small Cell Lung Cancer Patient, Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 41-43, 2017
  • AYTEKIN AYDIN,SAHIN SÜLEYMAN,ÇIFTÇILER RAFIYE,SAHINLI HAYRIYE,ESENDAGLI GÜLDAL,CIMER BETÜL,HACIOGLU MUHAMMET BEKIR,ÇILTAS AYDIN, Synchronous renal cell carcinoma and primary ocular malignant melanoma: case report, Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 44-46, 2017
  • GENÇ AHMED CIHAD,HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN,HACIBEKIROGLU ILHAN, Metastasis of Transitional Cell Carcinoma of the Bladder to the Orbit: A Case Report, Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 47-48, 2017
  • ÖNAL YILMAZ,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,KODAZ HILMI,TÜRKMEN BEKMEZ ESMA,HACIBEKIROGLU ILHAN,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Assessment of prognostic factors in epithelial ovarian cancer, Eurasian Journal of Medicine and Oncology, vol. 1, no. 2, pp. 61-68, 2017
  • KODAZ HILMI,HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN,ERDOGAN BÜLENT,TASTEKIN EBRU,KODAZ ELPEN ÇAGNUR,ÇIÇIN IRFAN, Combination of Docetaxel and Gemcitabine Ineffective in Metastatic Eccrine Porocarcinoma: A Case Report, Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 38-40, 2017
  • AYTEKIN AYDIN,SAHIN SÜLEYMAN,HACIOGLU MUHAMMET BEKIR,KARATAS FATIH,ALTINBAS MUSTAFA, Three-Year Disease-Free Survival After D2 Dissection and Liver Metastasectomy in a Gastric Cancer Case with Poor Prognostic Factors: A Case Report, Akdeniz Medical Journal, vol. 3, no. 1, pp. 49-51, 2017
  • A Rare Cause of Acute Kidney Injury:Renal Arterial Thrombosis in a Small Cell Lung Cancer Patient. Osman Kostek, Muhammet Bekir Hacioglu, Seval Orman, Ceren Cetin, Nil Su Kodal, Bulent Erdogan, Sernaz Uzunoglu, Irfan Cicin.EJMO. 2017; 1(1): 41-43
  • Metastasis of Transitional Cell Carcinoma of the Bladder to the Orbit: A Case Report. Ahmed Cihad Genc, Muhammet Bekir Hacioglu, Osman Kostek, Ilhan Hacibekiroglu. EJMO 2017;1(1):47–48
  • Synchronous Renal CellCarcinoma and Primary Ocular Malignant Melanoma: Case Report. Aydin Aytekin, Suleyman Sahin, Rafiye Ciftciler, Hayriye Sahinli, Guldal Esendagli, Betül Cimer, Muhammet Bekir Hacioglu, Aydin Ciltas. EJMO. 2017; 1(1): 44-46
  • Combination of Docetaxel and Gemcitabine Ineffective in Metastatic Eccrine Porocarcinoma: A Case Report. Hilmi Kodaz, Muhammet Bekir Hacioglu, Osman Kostek, Bulent Erdogan, Ebru Tastekin, Cagnur Elpen Kodaz, Irfan Cicin. EJMO. 2017; 1(1): 38-40
  • Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer-Review. Hilmi Kodaz, Osman Kostek, Muhammet Bekir Hacioglu, Bulent Erdogan, Cagnur Elpen Kodaz, Ilhan Hacibekiroglu, Esma Turkmen, Sernaz Uzunoglu, Irfan Cicin. EJMO2017;1(1):1–7
    4
    ATIF
  • KODAZ HILMI,HACIOGLU MUHAMMET BEKIR,ELPEN KODAZ ÇAGNUR,ÇINKAYA AHMET,ERDOGAN BÜLENT,ÇIÇIN IRFAN, Endometrial carcinoma and paraneoplastic immune thrombocytopenia, Journal of Oncological Science, vol. 2, no. 1, pp. 25-26, 2016
  • AYTEKIN AYDIN,SAHIN SÜLEYMAN,HACIOGLU MUHAMMET BEKIR,KARATAS FATIH,GÜRÇAY NESRIN,ALTINBAS MUSTAFA, Isolated inguinal lymph node metastasis in early stagetesticular seminoma: a case report and review of theliterature, European Journal of Oncology, vol. 21, no. 3, pp. 200-203, 2016
  • HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN,ERDOGAN BÜLENT,KODAZ HILMI,HACIBEKIROGLU ILHAN,TÜRKMEN ESMA,UZUNOGLU SERNAZ,ÇIÇIN IRFAN, Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report, Journal of Oncological Sciences, vol. 2, no. 2-3, pp. 69-70, 2016
  • Durable response with medroxiprogesterone acetate in metastatic renalcell carcinoma: Case report, Hacioglu BM, Kostek O, Erdogan B, Kodaz H, Hacibekiroglu I, Turkmen E,Uzunoglu S, Cicin I. Journal of Oncological Science, 2016, 2(2-3), 69-70
  • Endometrial carcinoma and paraneoplastic immune thrombocytopenia. Kodaz H, Hacıoglu MB, Elpen Kodaz Ç, Cınkaya A, Erdogan B, Çıçın I. Journal of Oncological Science, 2016,2(1), 25-26
  • Isolated inguinal lymph node metastasis in early stage testicularseminoma: a case report and review of the literature. Aydin Aytekin, Suleyman Sahin, Muhammet Bekir Hacioglu, Fatih Karatas, NesrinGurcay, Mustafa Altinbas. EUR. J. ONCOL.; Vol. 21, n. 3, pp. 200-203, 2016
  • Diabetic and Nondiabetic Coronary Heart Disease with Patient Fibrinogen and Middle Platelet Volume for Atherosclerosis. MB Hacıoğlu, EG Altunoğlu, F Erdenen, E Ülgen, C Müderrisoğlu. , İstanbul Med J 2014; 15: 161-5
  • A Case of Constrictive Pericarditis with Ascites and Lower Extremities Varices, EG Altunoğlu, S Yurdakul, B Hacıoğlu, N Özbaş, Ç Alkoç, E Ülgen, İstanbul Med J 2013;14: 297-9
  • A patient withincomplete Behcet's disease presenting with portal vein thrombosis/Portal ven trombozu ile seyreden inkomplet Behcet hastaligi olan bir olgu sunumu. Esma Guldal Altunoglu, Bekir Hacioglu, Ender Ulgen, Feray Aktas, Cigdem Bulut, Sevinc Yardimci, Zeynep Kemik, Yurdaer Ozcan, Esen Karakas, Ismail Yildiz. Istanbul Medical Journal, vol. 13,no. 2, 2012, p. 101+
  • Renal Involvement İn The Laurence Moon Biedl Syndrome: A Case Report. Esma Güldal Altunoğlu, Ender Ülgen, Yurdaer Özcan, Hamza Aslanhan, Bekir Hacıoğlu. istanbul Tıp Derg - Istanbul Med J 2010;11(4):175-178

Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler (Proceedings)

  • HACIOGLU MUHAMMET BEKIR,KÖSTEK OSMAN, METASTATIK KOLOREKTAL KANSERLERDE REGORAFENIB ETKINLIGI SAG-SOL FARKI VAR MI?, TREATMENT MODALITIES FOR STAGE IV DISEASES FOR COLORECTAL CANCER 6 th MEETING, ISTANBUL-TÜRKIYE
  • KARATAS FATIH,SAHIN SÜLEYMAN,HACIOGLU MUHAMMET BEKIR,ERDEM GÖKMEN UMUT,AYTEKIN AYDIN,INCI FATIH,YAZILITAS DOGAN,CILBIR EBRU, THE COMPARISON OF LEFT-VERSUS RIGHT-SIDED COLON CANCER, 7. INTERNATIONAL GASTROINTESTINAL CANCERS CONFERENCE, pp. 9-9, ISTANBUL-TÜRKIYE
  • TURAL DENIZ,KARACA MUSTAFA,HACIOGLU MUHAMMET BEKIR,BILGETEKIN IREM,BILGIN BURAK,KOÇOGLU HAKAN,ÖZET GÜLSÜM,ERDOGAN BÜLENT,SENDUR MEHMET ALI NAHIT,AYTEKIN AYDIN,BENEKLI MUSTAFA,ÖZET AHMET, Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival., ASCO 2016, vol. 34, no. 15_suppl, pp. 12518-12518, CHICAGO-AMERIKA BIRLESIK DEVLETLERI
  • ALDEMIR MEHMET NACI,TÜRKELI MEHMET,HACIOGLU MUHAMMET BEKIR,SAKIN ABDULLAH,YAMAN EMEL,ÇOBAN EZGI,KOCA DOGAN,KARACA MUSTAFA,SIMSEK MEHMET,BAHÇECI AYKUT,SEN ERDEM,EREN TÜLAY,ALIUSTAOGLU BASAK,SAKALAR TEOMAN,NURHAN ÖNAL KALKAN,AKTAS GÖKMEN,BILICI MEHMET,TURHAL SERDAR,BENEKLI MUSTAFA,TEKIN SALIM BASOL, Efficacy and tolerability of first-line chemotherapy in elderly patients (age =70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO), ESMO 2016, vol. 27, no. suppl_6
  • Receptor discordance after neoadjuvant chemotherapyand its impact on disease-free survival. Deniz Tural, Mustafa Karaca, Bekir Hacioglu, Irem Bilgetekin, Burak Bilgin,Hakan Kocoglu, Gulsum Ozet, Bulent Erdogan, Mehmet Ali Nahit Sendur, Aydin Aytekin,Mustafa Benekli, Ahmet Ozet. 2016 American Society of Clinical OncologyAnnual Meeting, June 3-7, 2016; Chicago, Illinois
  • Efficacy and tolerability of first-linechemotherapy in elderly patients (age ≥70 years) with metastatic gastric cancer: a multicenterstudy of the Anatolian Society of Medical Oncology (ASMO). MN Aldemir, M Turkeli, B Hacioglu, A Sakin, E Yaman, E Coban, D Koca, MKaraca, M Simsek, A Bahceci, E Sen, T Eren, BÖ Aliustaoglu, T Sakalar, NO Kalkan, GAktas, M Bilici, S Turhal, M Benekli, SB Tekin. 2016 American Society ofClinical Oncology Annual Meeting, June 3-7, 2016; Chicago, Illinois
  • The significance of the serum leptin,ghrelin, tumor necrosis factor alpha and interleukine-1 levels in patients with non-small cell lung cancer. Fatih Karatas, Bulent Yalcin, Hakan Akbulut, Gungor Utkan, Suleyman Sahin, Ahmet Demirkazik, Bekir Hacioglu, Fikri Icli. 2015 American Society of Clinical Oncology Annual Meeting, May 29-June 2, 2015; Chicago, Illinois
  • A Rare Cause In The Etıology Of HepatocellularCancer: Clomıpramıne Hydrochlorıde. Fatih Karataş, Süleyman Şahin, Muhammet Bekir Hacıoğlu, Aydın Aytekin, EbruSarı, Tamer Selen, Mustafa Altınbaş. December 12 - 14, 2014 – İstanbul/ Turkey 4thInternational Gastrointestinal Cancers Conference- Ps-018 (Aralık 2014)
  • A Good 5 Year Survıval Rate After Multıple SurgıcalResectıon Of Multıple Metastases From Mucınous Adenocarcınoma Of Colon. Muhammet Bekir Hacıoğlu, Süleyman Şahin., Aydın Aytekin., Fatih Karataş, EbruSarı, Tamer Selen, Mustafa Altınbaş. December 12- 14, 2014 – İstanbul/ Turkey 4th International Gastrointestinal Cancers Conference-Ps-043 (Aralık 2014)
  • Synchronous Bladder And Prostate Cancer In APatıent Prevıously Dıagnosed Wıth Gastrıc Cancer: Trıple Multıple Prımary Tumors. Muhammet Bekir Hacıoğlu, Süleyman Şahin, Aydın Aytekin, Fatih Karataş,Tamer Selen, Ebru Sarı, Mustafa Altınbaş. December 12 - 14, 2014 – İstanbul/ Turkey 4th International Gastrointestinal Cancers Conference- Ps-019 (Aralık 2014)

Ulusal Hakemli Dergilerde Yayınlanan Makaleler

  • KÜÇÜKARDA AHMET, GÖKYER ALI, sayin Sezin, Gökmen Ivo, ÖZCAN ERKAN, KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, ERDOGAN BÜLENT, Prognostic Factors for Survival in Transverse Colon Cancers, Journal of Gastrointestinal Cancer, 2021
  • KÜÇÜKARDA AHMET, GÖKYER ALI, Gökmen Ivo, ÖZCAN ERKAN, HACIOGLU MUHAMMET BEKIR, ERDOGAN BÜLENT, UZUNOGLU SERNAZ, ÇIÇIN IRFAN, El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata metastásico resistente a la castración tratado con acetato de abiraterona o enzalutamida, Actas Urológicas Españolas, 2021
  • KÜÇÜKARDA AHMET,GÖKYER ALI,GÖKMEN IVO,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,UZUNOGLU SERNAZ,ERDOGAN BÜLENT,ÇIÇIN IRFAN, Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis, Journal of oncological sciences, vol. 6, no. 3, pp. 133-140, 2020
  • GÖKYER ALI,KÜÇÜKARDA AHMET,KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR,ISSEVER KUBILAY,ÖZLER TALAR,ÇEVIK GÖKHAN,UZUNOGLU SERNAZ,ERDOGAN BÜLENT,ÇIÇIN IRFAN, Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience, Journal of oncological sciences, vol. 6, no. 3, pp. 141-146, 2020
  • HACIOGLU MUHAMMET BEKIR,SAHIN SÜLEYMAN, Treatment Outcomes of HER-2 Positive Metastatic Breast Cancer Patients Treated with Pertuzumab in the First Line Setting- Real Life Experience, Van Medical Journal, vol. 26, no. 2, pp. 254-260, 2019
  • SAHIN SÜLEYMAN,HACIOGLU MUHAMMET BEKIR, Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study, Istanbul Medical Journal, vol. 20, no. 2, pp. 82-87, 2019
  • S. SAHIN, B. M. HACIOGLU, Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study, Istanbul Medical Journal, vol. 20, no. 2, pp. 82-87, 4, 2019
  • ALTINBAS MUSTAFA,HEPSEN SEMA,IMAMOGLU GÖKSEN INANÇ,SARI EBRU,KÖSE NAZIYET,KARATAS FATIH,HACIOGLU MUHAMMET BEKIR,AYTEKIN AYDIN,ERSOY UGUR, Kanser Hastalarinin Ölüm Nedenleri ve Sagkalimi Etkileyen Faktörler, Sakarya Medical Journal, vol. 5, no. 1, pp. 5-9, 2015

Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler

  • KÖSTEK OSMAN,HACIOGLU MUHAMMET BEKIR, PAZOPANIBIN TEDAVI ETKINLIGI DEGERLENDIRMEDE SISTEMIK INFLAMASYON BELIRTEÇLERI, KONYA MULTIDISIPLINER ONKOLOJI SEMPOZYUMU, KONYA-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR, HEDEFE YÖNELIK TEDAVIDE TARTISMALI KONULAR-HEPATOSELLÜLER KANSER, 3. MUGLA MULTIDISIPLINER ONKOLOJIK ARASTIRMALAR KONGRESI, pp. 56-57, MUGLA-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR,SAHIN SÜLEYMAN, HEMOGRAMDAKI INFLAMATUAR BELIRTEÇLERIN METASTATIK KOLON KANSERINDEKI ÖNEMI, 2. ULUSAL IMMÜNOTERAPI VE ONKOLOJI KONGRESI, pp. 34, ANTALYA-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR, METASTATIK SAG KOLON TÜMÖRLERINDE BEVASIZUMAB ETKINLIGI, GENÇLERLE ONKOLOJIYE BAKIS KONGRESI, ANTALYA-TÜRKIYE
  • KARACA MUSTAFA,TURAL DENIZ,HACIOGLU MUHAMMET BEKIR,BILGETEKIN IREM,BILGIN BURAK,AYTEKIN AYDIN,ERDOGAN BÜLENT,SENDUR MEHMET ALI NAHIT,ÖZET GÜLSÜM,BENEKLI MUSTAFA,ÖZET AHMET, NEOADJUVAN KEMOTERAPI SONRASI RESEPTÖR DISKORDANSI VE HASTALIKSIZ SAGKALIM ÜZERINE ETKISI, 6. TÜRK TIBBI ONKOLOJI KONGRESI, ANTALYA-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR,SAHIN SÜLEYMAN,AYTEKIN AYDIN,KARATAS FATIH,SARI EBRU,IMAMOGLU GÖKSEN INANÇ,ALTINBAS MUSTAFA, THYROID CARCINOMA WITH METACHRONOUS BREAST CANCER-A CASE REPORT, 3. KARADENIZ MEME KONGRESI, SAMSUN-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR,KARATAS FATIH,AYTEKIN AYDIN,SAHIN SÜLEYMAN,IMAMOGLU GÖKSEN INANÇ,SARI EBRU,ALTINBAS MUSTAFA, KARACIGER METASTAZEKTOMISININ MIDE KANSERINDE YASAM SÜRESI ÜZERINE OLUMLU ETKISI: OLGU SUNUMU, 21. ULUSAL KANSER KONGRESI, ANTALYA-TÜRKIYE

Yazılan Ulusal Kitaplar veya Kitaplarda Bölümler

  • B. M. HACIOĞLU, B. ERDOĞAN, İ. ÇİÇİN, GEBELİKTE SARKOM TEDAVİSİ, Ulusal, Bölüm: GEBELİK VE SARKOMLAR, Basım Türü: Basılı, pp. 195-207, TÜRKİYE-, ISBN978-975-277-675-3, GÜNEŞ TIP KİTAPEVİ, 20171. Basım (Ocak 2017)

Editörlük / Yayınlama

  • Eurasian Journal of Medical Investigation ( EJMI ), Ulusal, TÜRKİYE-, Kare Publishing,
  • Eurasian Journal of Medicine and Oncology (EJMO), Ulusal, TÜRKİYE-, Kare Publishing,

Projeler

  • ESZAMANLI KEMORADYASYON TEDAVISININ ARDINDAN PROGRESE OLMAYAN EVRE I-III SINIRLI HASTALIK KÜÇÜK HÜCRELI AKCIGER KANSERI BULUNAN HASTALARDA KONSOLIDASYON TEDAVISI OLARAK DURVALUMAB YA DA DURVALUMAB VE TREMELIMUMAB’IN VERILDIGI FAZ III, RANDOMIZE, ÇIFT KÖR, PLASEBO KONTROLLÜ, ÇOK MERKEZLI, ULUSLARASI BIR ÇALISMA (ADRIATIC), TRAKYA ÜNIVERSITESI, 2019
  • REZEKE EDILEMEYEN LOKAL OLARAK ILERLEMIS YA DA METASTATIK ÜROTELYAL KANSER BULUNAN HASTALARDA TEK BASINA STANDART BAKIM KEMOTERAPISINE KARSI STANDART BAKIM KEMOTERAPISI ILE KOMBINE OLARAK ILK BASAMAK DURVALUMAB VE TREMELIMUMAB VE STANDART KEMOTERAPI TEDAVISI ILE KOMBINE OLARAK DURVALUMABIN KARSILASTIRILDIGI, FAZ III, RANDOMIZE, AÇIK ETIKETLI, KONTROLLÜ, ÇOK MERKEZLI, GLOBAL BIR ÇALISMA (NILE), TRAKYA ÜNIVERSITESI, 2019
  • ILERI VE/VEYA METASTATIK SOLID TÜMÖRÜ OLAN HASTALARDA, FIBROBLAST AKTIVASYON PROTEIN-A’YI (FAP) HEDEFLEYEN INTERLÖKIN-2 VARYANTINDAN (IL-2V) OLUSMUS BIR IMMUNOSITOKIN OLAN RO6874281’IN INTRAVENÖZ UYGULANDIGI, ATEZOLIZUMAB (ANTI PD-L1) ILE KOMBINASYONUNDA TERAPATIK AKTIVITESININ DEGERLENDIRILDIGI, AÇIK ETIKETLI, ÇOK MERKEZLI, FAZ II ÇALISMA, TRAKYA ÜNIVERSITESI, 2019
  • NEFREKTOMI SONRASI METASTAZ GELISIMI AÇISINDAN YÜKSEK RISK ALTINDAKI RENAL HÜCRELI KARSINOM HASTALARINDA ADJUVAN TEDAVI OLARAK ATEZOLIZUMAB (ANTI-PD-L1 ANTIKOR) ILE ILGILI FAZ III, ÇOK MERKEZLI, RANDOMIZE, PLASEBO KONTROLLÜ, ÇIFT KÖR ÇALISMA, TRAKYA ÜNIVERSITESI, 2019
  • METASTATIK PROSTAT KANSERLI HASTALARIN TEDAVISINDE NIRAPARIB’IN ABIRATERON ASETAT VE PREDNIZON ILE KOMBINASYONUNUN, YALNIZ ABIRATERON ASETAT VE PREDNIZOM ILE KARSILASTIRILDIGI FAZ 3, RANDOMIZE, PLASEBO KONTROLLÜ, ÇIFT KÖR ÇALISMA, TRAKYA ÜNIVERSITESI, 2019
  • METASTATIK ÜÇLÜ NEGATIF MEME KANSERI IÇIN ARASTIRMACININ SEÇIMINE GÖRE TEK AJAN KEMOTERAPIYE KARSI TEK AJAN PEMBROLIZUMABI KARSILASTIRAN RANDOMIZE, AÇIK ETIKETLI, FAZ III ÇALISMA (mTNBC)-(KEYNOTE-119), TRAKYA ÜNIVERSITESI, 2016-2016
  • METASTATIK HORMONA DUYARLI PROSTAT KANSERLI (mHSPC) GÖNÜLLÜLERDE ANDROJEN DEPRIVASYON TEDAVISI (ADT) KARSISINDA APALUTAMID ILE ADT KOMBINASYON TEDAVISININ ARASTIRILDIGI RANDOMIZE, PLASEBO KONTROLLÜ, ÇIFT KÖR FAZ 3 ÇALISMA, (TITAN), TRAKYA ÜNIVERSITESI, 2016-2016
  • GASTRIK VEYA GASTROÖZEFAJIAL BILESKE ADENOKARSINOM HASTALARINDA RAMUSIRUMAB’IN 4 DOZ REJIMININ FARMAKOKINETIK VE GÜVENLILIK AÇISINDAN DEGERLENDIRILDIGI RANDOMIZE FAZ 2 ÇALISMA, TRAKYA ÜNIVERSITESI, 2016-2016
  • YAYGIN EVRE KÜÇÜK HÜCRELI AKCIGER KANSERLI HASTALARDA LY2606368’NIN KULLANILDIGI BIR FAZ 2 ÇALISMA, TRAKYA ÜNIVERSITESI, 2016-2016
  • ILERI EVRE VEYA METASTATIK SAFRA YOLLARI KANSER HASTALARINDA BIRINCI BASAMAK TEDAVI OLARAK, SISPLATIN VE GEMSITABIN ILE BIRLIKTE RAMUSIRUMAB VEYA MERESTINIB VEYA PLASEBONUN VERILDIGI RANDOMIZE, ÇIFT-KÖR, FAZ 2 ÇALISMA, TRAKYA ÜNIVERSITESI, 2016-2016
  • KASTRASYONA DIRENÇLI METASTATIK PROSTAT KANSERI (mKDPK) OLAN GÖNÜLLÜLERDE PEMBROLIZUMABIN (MK-3475)FAZ II ÇALISMASI (KEYNOTE-199), TRAKYA ÜNIVERSITESI, 2016
  • ILERLEMIS SOLID TÜMÖRLERDE ATEZOLIZUMAB’IN DEGERLENDIRILDIGI AÇIK ETIKETLI ÇOK KOHORTLU, FAZ II ÇALISMASI, TRAKYA ÜNIVERSITESI, 2016-2016
  • DAHA ÖNCE SISTEMIK TEDAVI ALMAMIS, HORMON RESEPTÖ POZITIF HER2 NEGATIF MENAPOZ SONRASI LOKAL REKÜRREN YA DA METASTATIK MEME KANSERLI KADINLARDA NONSTEROIDAL AROMATAZ INHIBITÖRLERI (ANASTRAZOLE YA DA LETROZOLE) ILE BIRLIKTE BIR CDK4/6 INHIBITÖRÜ OLAN LY2835219 YA DA PLASEBONUN KARSILASTIRILDIGI PLASEBO KONTROLLÜ RANDOMIZE ÇIFT KÖR ÇALISMASI-MONARCH 3, TRAKYA ÜNIVERSITESI, 2015-2015
  • 2. BASAMAK METASTATIK VEYA LOKAL ILERI, REZEKE EDILEMEYEN GASTRIK YA DA GASTROÖZEFAJEAL BILESKELI ADENOKARSINOMDA, PAKLITAKSEL ILE BIRLIKTE ALTERNATIF RAMUSIRUMAB DOZLARININ DEGERLENDIRILDIGI RANDOMIZE FAZ 2 ÇALISMA, TRAKYA ÜNIVERSITESI, 2015-2015

Diğer

  • Gökmen Ivo, HACIOGLU MUHAMMET BEKIR, Immünoterapilerin Yan Etki Yönetimi, Türkiye Klinikleri
  • KÖSTEK OSMAN, HACIOGLU MUHAMMET BEKIR, ONKOLOJIK ACILLER, AKADEMISYEN TIP KITABEVI, ANKARA-TÜRKIYE
  • HACIOGLU MUHAMMET BEKIR,ÇIÇIN IRFAN, Immünoterapilerde Yan Etki Yönetimi, Türkiye Klinikleri, Ankara-TÜRKIYE
  • B. M. HACIOGLU, I. ÇIÇIN, Immünoterapilerde Yan Etki Yönetimi, Ulusal, Bölüm: Immünoterapilerin Nadir Toksisiteleri ve Yönetimi, Basim Türü: Basili, pp. 120-144, TÜRKIYE-Ankara, ISBN978-605-7650-02-3, Türkiye Klinikleri, 20191. Basim
  • B. M. HACIOGLU, B. ERDOGAN, I. ÇIÇIN, GEBELIKTE KANSER TEDAVISI, Ulusal, Bölüm: GEBELIK VE SARKOMLAR, Basim Türü: Basili, pp. 195-205, TÜRKIYE-ANKARA, ISBN978-975-277-675-3, GÜNES TIP KITABEVI, 20191. Basim
  • HACIOGLU MUHAMMET BEKIR,ERDOGAN BÜLENT,ÇIÇIN IRFAN, GEBELIKTE KANSER TEDAVISI, GÜNES TIP KITABEVI, ANKARA-TÜRKIYE